Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations

Prostacyclin pathway agents are a critical treatment for patients with pulmonary arterial hypertension. Seven prostacyclin pathway agents are available, including agents administered by parenteral infusion, by inhalation, and orally. Pulmonary arterial hypertension patients are now transitioned from...

Descripción completa

Detalles Bibliográficos
Autores principales: Sargent, Therese, Hansen, Lillian, Hohsfield, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297490/
https://www.ncbi.nlm.nih.gov/pubmed/32595933
http://dx.doi.org/10.1177/2045894020931324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297490/
https://www.ncbi.nlm.nih.gov/pubmed/32595933
http://dx.doi.org/10.1177/2045894020931324

Ejemplares similares